AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE Drug Patent Profile

✉ Email this page to a colleague

Amlodipine Besylate And Benazepril Hydrochloride is a drug marketed by Amneal, Apotex, Aurobindo Pharma Ltd, Dr Reddys Labs Inc, Lupin Pharms, Norvium Bioscience, Strides Pharma, Teva Pharms, Watson Labs, and Watson Labs Inc. and is included in twelve NDAs.

The generic ingredient in AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE is amlodipine besylate; benazepril hydrochloride. There are fifty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the amlodipine besylate; benazepril hydrochloride profile page.

A generic version of AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE was approved as amlodipine besylate; benazepril hydrochloride by LUPIN PHARMS on February 5^th, 2010.

What is the 5 year forecast for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE?
What are the global sales for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE?
What is Average Wholesale Price for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE?

US Patents:	0
Applicants:	10
NDAs:	12
Finished Product Suppliers / Packagers:	14
Raw Ingredient (Bulk) Api Vendors:	2
Clinical Trials:	6
Patent Applications:	12
What excipients (inactive ingredients) are in AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE?	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE excipients list
DailyMed Link:	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE at DailyMed

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Shanghai Jiao Tong University School of Medicine	Phase 4
Novartis Pharmaceuticals	Phase 4
Dr. Reddy's Laboratories Limited	Phase 1

Drug Class	Angiotensin Converting Enzyme Inhibitor Calcium Channel Blocker Dihydropyridine Calcium Channel Blocker
Mechanism of Action	Angiotensin-converting Enzyme Inhibitors Calcium Channel Antagonists Cytochrome P450 3A Inhibitors
Physiological Effect	Decreased Blood Pressure

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Pharms	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	077179-001	May 18, 2007		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Norvium Bioscience	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	079047-001	Jul 5, 2011		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	077890-003	Oct 14, 2010	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Pharms	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	077179-004	May 18, 2007		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	077890-004	Oct 14, 2010	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration